Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hornedo

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 1, 1983
Intracranial tumors with risk of dissemination in neuroaxisF A Calvo, J Hornedo, A de la Torre, et al.
Medical and Pediatric Oncology|January 1, 1988
Rhabdomyosarcoma presenting with diffuse bone marrow involvement, hypercalcemia and renal failureF Javier de la Serna, M A Martinez, M D Valdes, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplantsM Hidalgo, J Hornedo, C Lumbreras, et al.
Seminars in Oncology|January 14, 1998
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancerR Hitt, L Paz-Ares, M Hidalgo, et al.
Bone Marrow Transplantation|June 1, 2002
The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant periodJ Hornedo, C Solá, C Solano, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domainR Colomer, A Llombart-Cussac, I Tusquets, et al.
Revista Espanola De Medicina Nuclear|November 1, 2003
[Positron emission tomography in a patient with Von Recklinghausen disease and left dorsal neurofibrosarcoma]G Ruíz-Hernández, J Hornedo-Muguiro, P Salinas-Hernández, et al.
Cancer|January 28, 1999
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trialM Hidalgo, J Hornedo, C Lumbreras, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 1999
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxisS Perea, M Hidalgo, A Arcediano, et al.
Leukemia|February 20, 2003
Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapyF Prósper, C Solá, J Hornedo, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|September 1, 1983
Intracranial tumors with risk of dissemination in neuroaxisF A Calvo, J Hornedo, A de la Torre, et al.
Medical and Pediatric Oncology|January 1, 1988
Rhabdomyosarcoma presenting with diffuse bone marrow involvement, hypercalcemia and renal failureF Javier de la Serna, M A Martinez, M D Valdes, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplantsM Hidalgo, J Hornedo, C Lumbreras, et al.
Seminars in Oncology|January 14, 1998
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancerR Hitt, L Paz-Ares, M Hidalgo, et al.
Bone Marrow Transplantation|June 1, 2002
The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant periodJ Hornedo, C Solá, C Solano, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domainR Colomer, A Llombart-Cussac, I Tusquets, et al.
Revista Espanola De Medicina Nuclear|November 1, 2003
[Positron emission tomography in a patient with Von Recklinghausen disease and left dorsal neurofibrosarcoma]G Ruíz-Hernández, J Hornedo-Muguiro, P Salinas-Hernández, et al.
Cancer|January 28, 1999
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trialM Hidalgo, J Hornedo, C Lumbreras, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 1999
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxisS Perea, M Hidalgo, A Arcediano, et al.
Leukemia|February 20, 2003
Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapyF Prósper, C Solá, J Hornedo, et al.
Pageof 3